• 2025 Outlook with Stacie Dusetzina, Ph.D., Vanderbilt University

  • 2024/12/18
  • 再生時間： 48 分
  • ポッドキャスト

2025 Outlook with Stacie Dusetzina, Ph.D., Vanderbilt University

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this episode, we sit down with Stacie Dusetzina, Ph.D., a leading health economist from Vanderbilt University Medical Center to discuss the critical healthcare and policy trends shaping 2025. From shifts in federal leadership to the evolving impact of the Inflation Reduction Act, our guest provides expert insights on what to expect in drug pricing, health insurance, and patient access in the coming year. We explore how the public and private sectors are addressing affordability challenges and highlight innovative approaches to improve access to essential medications. With a focus on the future, this conversation offers a thoughtful outlook on the policies and market dynamics set to redefine healthcare in 2025.

    Stacie Dusetzina, Ph.D., Vanderbilt University

    Vanderbilt University Medical Center

    A primer on copay accumulators, copay maximizers, and alternative funding programs

    CMS
    FDA

    IRA

    Medicare Part D

    Pharmacy Benefit Managers (PBMs)

    Medicaid

    CMMI’s Medicaid group negotiation

    COVID-19

    Statins

    PCSK9 inhibitors

    Imatinib

    340B Drug Pricing Program

    Questions or comments?
    Email us at comments@prescriptionforbetteraccess.com.
    Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
    続きを読む 一部表示

あらすじ・解説

In this episode, we sit down with Stacie Dusetzina, Ph.D., a leading health economist from Vanderbilt University Medical Center to discuss the critical healthcare and policy trends shaping 2025. From shifts in federal leadership to the evolving impact of the Inflation Reduction Act, our guest provides expert insights on what to expect in drug pricing, health insurance, and patient access in the coming year. We explore how the public and private sectors are addressing affordability challenges and highlight innovative approaches to improve access to essential medications. With a focus on the future, this conversation offers a thoughtful outlook on the policies and market dynamics set to redefine healthcare in 2025.

Stacie Dusetzina, Ph.D., Vanderbilt University

Vanderbilt University Medical Center

A primer on copay accumulators, copay maximizers, and alternative funding programs

CMS
FDA

IRA

Medicare Part D

Pharmacy Benefit Managers (PBMs)

Medicaid

CMMI’s Medicaid group negotiation

COVID-19

Statins

PCSK9 inhibitors

Imatinib

340B Drug Pricing Program

Questions or comments?
Email us at comments@prescriptionforbetteraccess.com.
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
続きを読む 一部表示

2025 Outlook with Stacie Dusetzina, Ph.D., Vanderbilt Universityに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。